Asset Allocation

As of December 31, 2025.
Type % Net
Cash 0.46%
Stock 59.62%
Bond 38.13%
Convertible 0.00%
Preferred 0.00%
Other 1.78%
View Asset Allocation
Start Trial

Market Capitalization

As of December 31, 2025
Large 80.52%
Mid 16.97%
Small 2.52%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.41%    % Emerging Markets: 0.09%    % Unidentified Markets: 0.50%

Americas 97.66%
96.12%
Canada 87.14%
United States 8.97%
1.55%
Chile 0.00%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 1.28%
United Kingdom 0.50%
0.79%
Belgium 0.00%
France 0.36%
Germany 0.02%
Ireland 0.05%
Italy 0.34%
Netherlands 0.00%
Norway 0.00%
Spain 0.00%
0.00%
0.00%
Greater Asia 0.55%
Japan 0.55%
0.00%
0.00%
0.00%
Unidentified Region 0.50%

Bond Credit Quality Exposure

AAA 35.17%
AA 15.73%
A 19.12%
BBB 23.33%
BB 0.21%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.11%
Not Available 6.33%
Short Term 0.00%
As of December 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
32.41%
Materials
5.99%
Consumer Discretionary
3.50%
Financials
21.48%
Real Estate
1.44%
Sensitive
21.88%
Communication Services
1.36%
Energy
4.62%
Industrials
9.61%
Information Technology
6.29%
Defensive
6.08%
Consumer Staples
3.56%
Health Care
0.57%
Utilities
1.95%
Not Classified
39.63%
Non Classified Equity
0.33%
Not Classified - Non Equity
39.31%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 23.08%
Corporate 42.62%
Securitized 2.21%
Municipal 21.64%
Other 10.44%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.48%
Less than 1 Year
0.48%
Intermediate
59.53%
1 to 3 Years
6.96%
3 to 5 Years
15.66%
5 to 10 Years
36.91%
Long Term
38.05%
10 to 20 Years
14.77%
20 to 30 Years
18.16%
Over 30 Years
5.12%
Other
1.95%
As of December 31, 2025
View Bond Maturity Exposure
Start Trial